Familial Amyloid Polyneuropathy Therapeutic and Forecast Market
1 Introduction to Research & Analysis Reports
1.1 Familial Amyloid Polyneuropathy Therapeutic Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Familial Amyloid Polyneuropathy Therapeutic Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Familial Amyloid Polyneuropathy Therapeutic Overall Market Size
2.1 Global Familial Amyloid Polyneuropathy Therapeutic Market Size: 2022 VS 2029
2.2 Global Familial Amyloid Polyneuropathy Therapeutic Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Familial Amyloid Polyneuropathy Therapeutic Players in Global Market
3.2 Top Global Familial Amyloid Polyneuropathy Therapeutic Companies Ranked by Revenue
3.3 Global Familial Amyloid Polyneuropathy Therapeutic Revenue by Companies
3.4 Top 3 and Top 5 Familial Amyloid Polyneuropathy Therapeutic Companies in Global Market, by Revenue in 2022
3.5 Global Companies Familial Amyloid Polyneuropathy Therapeutic Product Type
3.6 Tier 1, Tier 2 and Tier 3 Familial Amyloid Polyneuropathy Therapeutic Players in Global Market
3.6.1 List of Global Tier 1 Familial Amyloid Polyneuropathy Therapeutic Companies
3.6.2 List of Global Tier 2 and Tier 3 Familial Amyloid Polyneuropathy Therapeutic Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Familial Amyloid Polyneuropathy Therapeutic Market Size Markets, 2022 & 2029
4.1.2 Inotersen
4.1.3 Tafamidis
4.1.4 Patisiran
4.1.5 Others
4.2 By Type - Global Familial Amyloid Polyneuropathy Therapeutic Revenue & Forecasts
4.2.1 By Type - Global Familial Amyloid Polyneuropathy Therapeutic Revenue, 2018-2023
4.2.2 By Type - Global Familial Amyloid Polyneuropathy Therapeutic Revenue, 2024-2029
4.2.3 By Type - Global Familial Amyloid Polyneuropathy Therapeutic Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Familial Amyloid Polyneuropathy Therapeutic Market Size, 2022 & 2029
5.1.2 Hospital Pharmacies
5.1.3 Retail Pharmacies
5.1.4 Online Pharmacies
5.1.5 Others
5.2 By Application - Global Familial Amyloid Polyneuropathy Therapeutic Revenue & Forecasts
5.2.1 By Application - Global Familial Amyloid Polyneuropathy Therapeutic Revenue, 2018-2023
5.2.2 By Application - Global Familial Amyloid Polyneuropathy Therapeutic Revenue, 2024-2029
5.2.3 By Application - Global Familial Amyloid Polyneuropathy Therapeutic Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Familial Amyloid Polyneuropathy Therapeutic Market Size, 2022 & 2029
6.2 By Region - Global Familial Amyloid Polyneuropathy Therapeutic Revenue & Forecasts
6.2.1 By Region - Global Familial Amyloid Polyneuropathy Therapeutic Revenue, 2018-2023
6.2.2 By Region - Global Familial Amyloid Polyneuropathy Therapeutic Revenue, 2024-2029
6.2.3 By Region - Global Familial Amyloid Polyneuropathy Therapeutic Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Familial Amyloid Polyneuropathy Therapeutic Revenue, 2018-2029
6.3.2 US Familial Amyloid Polyneuropathy Therapeutic Market Size, 2018-2029
6.3.3 Canada Familial Amyloid Polyneuropathy Therapeutic Market Size, 2018-2029
6.3.4 Mexico Familial Amyloid Polyneuropathy Therapeutic Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Familial Amyloid Polyneuropathy Therapeutic Revenue, 2018-2029
6.4.2 Germany Familial Amyloid Polyneuropathy Therapeutic Market Size, 2018-2029
6.4.3 France Familial Amyloid Polyneuropathy Therapeutic Market Size, 2018-2029
6.4.4 U.K. Familial Amyloid Polyneuropathy Therapeutic Market Size, 2018-2029
6.4.5 Italy Familial Amyloid Polyneuropathy Therapeutic Market Size, 2018-2029
6.4.6 Russia Familial Amyloid Polyneuropathy Therapeutic Market Size, 2018-2029
6.4.7 Nordic Countries Familial Amyloid Polyneuropathy Therapeutic Market Size, 2018-2029
6.4.8 Benelux Familial Amyloid Polyneuropathy Therapeutic Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Familial Amyloid Polyneuropathy Therapeutic Revenue, 2018-2029
6.5.2 China Familial Amyloid Polyneuropathy Therapeutic Market Size, 2018-2029
6.5.3 Japan Familial Amyloid Polyneuropathy Therapeutic Market Size, 2018-2029
6.5.4 South Korea Familial Amyloid Polyneuropathy Therapeutic Market Size, 2018-2029
6.5.5 Southeast Asia Familial Amyloid Polyneuropathy Therapeutic Market Size, 2018-2029
6.5.6 India Familial Amyloid Polyneuropathy Therapeutic Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Familial Amyloid Polyneuropathy Therapeutic Revenue, 2018-2029
6.6.2 Brazil Familial Amyloid Polyneuropathy Therapeutic Market Size, 2018-2029
6.6.3 Argentina Familial Amyloid Polyneuropathy Therapeutic Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Familial Amyloid Polyneuropathy Therapeutic Revenue, 2018-2029
6.7.2 Turkey Familial Amyloid Polyneuropathy Therapeutic Market Size, 2018-2029
6.7.3 Israel Familial Amyloid Polyneuropathy Therapeutic Market Size, 2018-2029
6.7.4 Saudi Arabia Familial Amyloid Polyneuropathy Therapeutic Market Size, 2018-2029
6.7.5 UAE Familial Amyloid Polyneuropathy Therapeutic Market Size, 2018-2029
7 Familial Amyloid Polyneuropathy Therapeutic Companies Profiles
7.1 Pfizer Inc.
7.1.1 Pfizer Inc. Company Summary
7.1.2 Pfizer Inc. Business Overview
7.1.3 Pfizer Inc. Familial Amyloid Polyneuropathy Therapeutic Major Product Offerings
7.1.4 Pfizer Inc. Familial Amyloid Polyneuropathy Therapeutic Revenue in Global Market (2018-2023)
7.1.5 Pfizer Inc. Key News & Latest Developments
7.2 Alnylam Pharmaceuticals Inc.
7.2.1 Alnylam Pharmaceuticals Inc. Company Summary
7.2.2 Alnylam Pharmaceuticals Inc. Business Overview
7.2.3 Alnylam Pharmaceuticals Inc. Familial Amyloid Polyneuropathy Therapeutic Major Product Offerings
7.2.4 Alnylam Pharmaceuticals Inc. Familial Amyloid Polyneuropathy Therapeutic Revenue in Global Market (2018-2023)
7.2.5 Alnylam Pharmaceuticals Inc. Key News & Latest Developments
7.3 Ionis Pharmaceuticals Inc.
7.3.1 Ionis Pharmaceuticals Inc. Company Summary
7.3.2 Ionis Pharmaceuticals Inc. Business Overview
7.3.3 Ionis Pharmaceuticals Inc. Familial Amyloid Polyneuropathy Therapeutic Major Product Offerings
7.3.4 Ionis Pharmaceuticals Inc. Familial Amyloid Polyneuropathy Therapeutic Revenue in Global Market (2018-2023)
7.3.5 Ionis Pharmaceuticals Inc. Key News & Latest Developments
7.4 Corino Therapeutics Inc.
7.4.1 Corino Therapeutics Inc. Company Summary
7.4.2 Corino Therapeutics Inc. Business Overview
7.4.3 Corino Therapeutics Inc. Familial Amyloid Polyneuropathy Therapeutic Major Product Offerings
7.4.4 Corino Therapeutics Inc. Familial Amyloid Polyneuropathy Therapeutic Revenue in Global Market (2018-2023)
7.4.5 Corino Therapeutics Inc. Key News & Latest Developments
7.5 Proclara Biosciences
7.5.1 Proclara Biosciences Company Summary
7.5.2 Proclara Biosciences Business Overview
7.5.3 Proclara Biosciences Familial Amyloid Polyneuropathy Therapeutic Major Product Offerings
7.5.4 Proclara Biosciences Familial Amyloid Polyneuropathy Therapeutic Revenue in Global Market (2018-2023)
7.5.5 Proclara Biosciences Key News & Latest Developments
7.6 Arcturus Therapeutics Inc
7.6.1 Arcturus Therapeutics Inc Company Summary
7.6.2 Arcturus Therapeutics Inc Business Overview
7.6.3 Arcturus Therapeutics Inc Familial Amyloid Polyneuropathy Therapeutic Major Product Offerings
7.6.4 Arcturus Therapeutics Inc Familial Amyloid Polyneuropathy Therapeutic Revenue in Global Market (2018-2023)
7.6.5 Arcturus Therapeutics Inc Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
List of Tables
Table 1. Familial Amyloid Polyneuropathy Therapeutic Market Opportunities & Trends in Global Market
Table 2. Familial Amyloid Polyneuropathy Therapeutic Market Drivers in Global Market
Table 3. Familial Amyloid Polyneuropathy Therapeutic Market Restraints in Global Market
Table 4. Key Players of Familial Amyloid Polyneuropathy Therapeutic in Global Market
Table 5. Top Familial Amyloid Polyneuropathy Therapeutic Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Familial Amyloid Polyneuropathy Therapeutic Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Familial Amyloid Polyneuropathy Therapeutic Revenue Share by Companies, 2018-2023
Table 8. Global Companies Familial Amyloid Polyneuropathy Therapeutic Product Type
Table 9. List of Global Tier 1 Familial Amyloid Polyneuropathy Therapeutic Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Familial Amyloid Polyneuropathy Therapeutic Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Familial Amyloid Polyneuropathy Therapeutic Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Familial Amyloid Polyneuropathy Therapeutic Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Familial Amyloid Polyneuropathy Therapeutic Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application ? Global Familial Amyloid Polyneuropathy Therapeutic Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Familial Amyloid Polyneuropathy Therapeutic Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Familial Amyloid Polyneuropathy Therapeutic Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region ? Global Familial Amyloid Polyneuropathy Therapeutic Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Familial Amyloid Polyneuropathy Therapeutic Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Familial Amyloid Polyneuropathy Therapeutic Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Familial Amyloid Polyneuropathy Therapeutic Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Familial Amyloid Polyneuropathy Therapeutic Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Familial Amyloid Polyneuropathy Therapeutic Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Familial Amyloid Polyneuropathy Therapeutic Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Familial Amyloid Polyneuropathy Therapeutic Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Familial Amyloid Polyneuropathy Therapeutic Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Familial Amyloid Polyneuropathy Therapeutic Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Familial Amyloid Polyneuropathy Therapeutic Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Familial Amyloid Polyneuropathy Therapeutic Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Familial Amyloid Polyneuropathy Therapeutic Revenue, (US$, Mn), 2024-2029
Table 30. Pfizer Inc. Company Summary
Table 31. Pfizer Inc. Familial Amyloid Polyneuropathy Therapeutic Product Offerings
Table 32. Pfizer Inc. Familial Amyloid Polyneuropathy Therapeutic Revenue (US$, Mn) & (2018-2023)
Table 33. Pfizer Inc. Key News & Latest Developments
Table 34. Alnylam Pharmaceuticals Inc. Company Summary
Table 35. Alnylam Pharmaceuticals Inc. Familial Amyloid Polyneuropathy Therapeutic Product Offerings
Table 36. Alnylam Pharmaceuticals Inc. Familial Amyloid Polyneuropathy Therapeutic Revenue (US$, Mn) & (2018-2023)
Table 37. Alnylam Pharmaceuticals Inc. Key News & Latest Developments
Table 38. Ionis Pharmaceuticals Inc. Company Summary
Table 39. Ionis Pharmaceuticals Inc. Familial Amyloid Polyneuropathy Therapeutic Product Offerings
Table 40. Ionis Pharmaceuticals Inc. Familial Amyloid Polyneuropathy Therapeutic Revenue (US$, Mn) & (2018-2023)
Table 41. Ionis Pharmaceuticals Inc. Key News & Latest Developments
Table 42. Corino Therapeutics Inc. Company Summary
Table 43. Corino Therapeutics Inc. Familial Amyloid Polyneuropathy Therapeutic Product Offerings
Table 44. Corino Therapeutics Inc. Familial Amyloid Polyneuropathy Therapeutic Revenue (US$, Mn) & (2018-2023)
Table 45. Corino Therapeutics Inc. Key News & Latest Developments
Table 46. Proclara Biosciences Company Summary
Table 47. Proclara Biosciences Familial Amyloid Polyneuropathy Therapeutic Product Offerings
Table 48. Proclara Biosciences Familial Amyloid Polyneuropathy Therapeutic Revenue (US$, Mn) & (2018-2023)
Table 49. Proclara Biosciences Key News & Latest Developments
Table 50. Arcturus Therapeutics Inc Company Summary
Table 51. Arcturus Therapeutics Inc Familial Amyloid Polyneuropathy Therapeutic Product Offerings
Table 52. Arcturus Therapeutics Inc Familial Amyloid Polyneuropathy Therapeutic Revenue (US$, Mn) & (2018-2023)
Table 53. Arcturus Therapeutics Inc Key News & Latest Developments
List of Figures
Figure 1. Familial Amyloid Polyneuropathy Therapeutic Segment by Type in 2022
Figure 2. Familial Amyloid Polyneuropathy Therapeutic Segment by Application in 2022
Figure 3. Global Familial Amyloid Polyneuropathy Therapeutic Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Familial Amyloid Polyneuropathy Therapeutic Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Familial Amyloid Polyneuropathy Therapeutic Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Familial Amyloid Polyneuropathy Therapeutic Revenue in 2022
Figure 8. By Type - Global Familial Amyloid Polyneuropathy Therapeutic Revenue Market Share, 2018-2029
Figure 9. By Application - Global Familial Amyloid Polyneuropathy Therapeutic Revenue Market Share, 2018-2029
Figure 10. By Type - Global Familial Amyloid Polyneuropathy Therapeutic Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Familial Amyloid Polyneuropathy Therapeutic Revenue Market Share, 2018-2029
Figure 12. By Application - Global Familial Amyloid Polyneuropathy Therapeutic Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Familial Amyloid Polyneuropathy Therapeutic Revenue Market Share, 2018-2029
Figure 14. By Region - Global Familial Amyloid Polyneuropathy Therapeutic Revenue Market Share, 2018-2029
Figure 15. By Country - North America Familial Amyloid Polyneuropathy Therapeutic Revenue Market Share, 2018-2029
Figure 16. US Familial Amyloid Polyneuropathy Therapeutic Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Familial Amyloid Polyneuropathy Therapeutic Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Familial Amyloid Polyneuropathy Therapeutic Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Familial Amyloid Polyneuropathy Therapeutic Revenue Market Share, 2018-2029
Figure 20. Germany Familial Amyloid Polyneuropathy Therapeutic Revenue, (US$, Mn), 2018-2029
Figure 21. France Familial Amyloid Polyneuropathy Therapeutic Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Familial Amyloid Polyneuropathy Therapeutic Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Familial Amyloid Polyneuropathy Therapeutic Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Familial Amyloid Polyneuropathy Therapeutic Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Familial Amyloid Polyneuropathy Therapeutic Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Familial Amyloid Polyneuropathy Therapeutic Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Familial Amyloid Polyneuropathy Therapeutic Revenue Market Share, 2018-2029
Figure 28. China Familial Amyloid Polyneuropathy Therapeutic Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Familial Amyloid Polyneuropathy Therapeutic Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Familial Amyloid Polyneuropathy Therapeutic Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Familial Amyloid Polyneuropathy Therapeutic Revenue, (US$, Mn), 2018-2029
Figure 32. India Familial Amyloid Polyneuropathy Therapeutic Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Familial Amyloid Polyneuropathy Therapeutic Revenue Market Share, 2018-2029
Figure 34. Brazil Familial Amyloid Polyneuropathy Therapeutic Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Familial Amyloid Polyneuropathy Therapeutic Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Familial Amyloid Polyneuropathy Therapeutic Revenue Market Share, 2018-2029
Figure 37. Turkey Familial Amyloid Polyneuropathy Therapeutic Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Familial Amyloid Polyneuropathy Therapeutic Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Familial Amyloid Polyneuropathy Therapeutic Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Familial Amyloid Polyneuropathy Therapeutic Revenue, (US$, Mn), 2018-2029
Figure 41. Pfizer Inc. Familial Amyloid Polyneuropathy Therapeutic Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Alnylam Pharmaceuticals Inc. Familial Amyloid Polyneuropathy Therapeutic Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Ionis Pharmaceuticals Inc. Familial Amyloid Polyneuropathy Therapeutic Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Corino Therapeutics Inc. Familial Amyloid Polyneuropathy Therapeutic Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Proclara Biosciences Familial Amyloid Polyneuropathy Therapeutic Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Arcturus Therapeutics Inc Familial Amyloid Polyneuropathy Therapeutic Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
